An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A person on an online forum says they're about to start Mounjaro (a prescription medicine) to try to lose about 40 pounds and because they're noticing growing problems with alcohol. Their doctor told them Mounjaro might reduce alcohol cravings, so they're hopeful and looking for information or experiences from others before they begin treatment this week. Mounjaro is the brand name for tirzepatide. It’s a lab-made drug that acts like certain gut hormones that tell your brain about hunger and fullness. In plain terms, it helps people feel less hungry, eat less, and often lose weight. It’s approved for weight loss and for improving blood sugar in people with type 2 diabetes. It’s given by injection under the skin, usually once a week, and it can take a few weeks to months to see steady effects. What’s interesting in this post is the hope that Mounjaro will reduce alcohol cravings. Some early research and patient reports suggest that drugs that change hunger and reward signals in the brain can sometimes affect cravings for things like alcohol. But the evidence is still limited. Most of the solid clinical trials for tirzepatide focused on weight loss and blood sugar, not alcohol use. There are anecdotal reports and small studies suggesting a possible reduction in alcohol intake, but nothing large and definitive yet. So we don’t have strong proof that it will reliably stop cravings for most people. Why this might matter: if a medication that helps with weight also reduces alcohol cravings, that could be a big deal for people trying to improve multiple health areas at once. Alcohol can add many extra calories, worsen sleep, and interfere with mental and physical health, so reducing drinking can speed up weight loss and improve overall wellbeing. For someone who is struggling with both weight and alcohol, a single treatment that helps with both would be appealing and more convenient than juggling multiple therapies. Caveats and risks are important. Mounjaro has side effects like nausea, diarrhea, constipation, and sometimes more serious but rare problems. It’s not a guaranteed fix for alcohol use disorder; people with significant alcohol dependence often need specialized addiction support, counseling, or specific medications. Also, doctors base recommendations on each person’s health history, so what one doctor predicts might not happen. Finally, tirzepatide is a prescription drug — it should be started and monitored by a clinician. If someone is drinking heavily, they should tell their provider; sudden changes in alcohol use or starting a new medication can have interactions and withdrawal risks. Bottom line: starting Mounjaro could help with weight and possibly affect alcohol cravings for some people, but the evidence for reducing drinking is still limited — talk openly with your doctor and have a plan for medical and emotional support.
Source: r/Mounjaro